Canadian food safety innovation Inneo gains FDA approval

The U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) grant GRAS (Generally Recognized as Safe) status to Inneo, a Canadian-made food processing aid for eliminating Listeria monocytogenes.

Developed by Quebec-based biotechnology company Innodal, the technology uses antimicrobial peptides to eliminate the harmful pathogen.

With this approval, Innodal is set to launch industrial-scale projects with U.S. processing companies, marking its entry into the U.S. market.

Inneo, Innodal’s flagship product, has been commercialized in Canada for four years.

Laurent Dallaire, CEO and co-founder at Innodal, said, “Achieving GRAS status for Inneo reinforces our commitment to innovation and food safety. This official recognition now allows American food processors to use Inneo in full compliance with FDA regulations, opening new possibilities. We are convinced that this new step will contribute to improving the quality and safety of food products globally.’’